Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Varicella
2021
Americas
Europe
Clear all
Type of publications
NITAG documentation
(136)
Systematic reviews (SYSVAC)
(5)
Topics
Available to download in languages
Regions
Americas
(64)
Europe
(77)
Africa
(17)
South-East Asia
(2)
Western Pacific
(15)
Countries
Argentina
(1)
Belgium
(15)
Bolivia
(2)
Canada
(16)
Chile
(9)
Denmark
(1)
France
(16)
Germany
(8)
Ireland
(7)
Netherlands
(7)
Spain
(1)
Sweden
(2)
United Kingdom
(19)
United States of America
(36)
Diseases
COVID-19
(140)
Varicella
(1)
Ebola
(1)
Hepatitis B
(1)
Human papillomavirus (HPV)
(5)
Influenza
(4)
Meningococcal disease
(1)
Pneumococcal disease
(1)
Rotavirus
(3)
Vaccine topics
Acceptance
(2)
Coverage
(3)
Ethical issues
(3)
Target population
Adolescents
(1)
Adults
(4)
All age groups
(3)
Children
(3)
Healthcare workers
(1)
Older adults
(2)
Parents/caregivers
(1)
Pregnant women
(5)
Risk group
(2)
Publication date
2021
(141)
2024
(2)
2023
(26)
2022
(74)
2020
(80)
2019
(4)
2017
(3)
2016
(2)
2015
(2)
2014
(2)
2013
(3)
2012
(2)
2011
(2)
2010
(9)
2009
(4)
2008
(1)
2007
(4)
2006
(1)
2005
(3)
1993
(1)
1991
(1)
141 results found
2021
∙
Haut Conseil de la santé publique
HAS statement relating to the possibility of carrying out a vaccination schedule with two mRNA vaccines of different specialties in exceptional situations - 29 April, 2021
2021
∙
Haute Autorité de Santé
HAS vaccination strategy against Covid-19 - Place of the COMIRNATY® mRNA vaccine in 12-15 year olds - 03 June, 2021
2021
∙
Kathleen Dooling, ACIP
Implementation considerations for COVID-19 Vaccines
2021
∙
NACI
Interim guidance on booster COVID-19 vaccine doses in Canada
2021
∙
ACIP
Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years
2021
∙
ACIP
Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines
2021
∙
Sara Oliver, ACIP
Janssen COVID-19 Vaccine - ACIP conclusion
2021
∙
JCVI
JCVI advice on the UK vaccine response to the Omicron variant
2021
∙
JCVI
JCVI advice on Third primary COVID-19 vaccine dose for people who are immunosuppressed - 1 September, 2021
2021
∙
JCVI
JCVI advice to mitigate impact of B1.617.2 variant - 14 May 2021
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register